791 Phase 2 study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676)

✍ Scribed by Necchi, A.; Mariani, L.; Giannatempo, P.; Fina, E.; Nicolai, N.; Pennati, M.; Zaffaroni, N.; Farè, E.; Piva, L.; Biasoni, D.; Catanzaro, M.; Torelli, T.; Stagni, S.; Maffezzini, M.; Colecchia, M.; Paolini, B.; Cappelletti, V.; Daidone, M.G.; Gianni, A.M.; Salvioni, R.

• Book ID: 122707345
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 201 KB
• Volume: 13
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(14)60779-X